Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-16 Purchase |
2022-12-19 4:22 pm |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
25,000 | $0.74 | $18,500 | 40,000 (Direct) |
View |
| 2022-08-17 Purchase |
2022-08-17 5:23 pm |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
15,000 | $1.8 | $27,000 | 15,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Option Award |
2025-02-14 4:13 pm |
N/A 2035-02-12 |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
371,800 | $0 | 371,800 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-22 08:04 am |
N/A 2034-03-20 |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
160,115 | $0 | 160,115 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-14 5:04 pm |
N/A 2033-02-12 |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
158,001 | $0 | 158,001 (Direct) |
View |
| 2022-02-25 Option Award |
2022-02-25 4:42 pm |
N/A 2032-02-24 |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
112,470 | $0 | 112,470 (Direct) |
View |
| 2021-11-01 Option Award |
2021-11-01 4:31 pm |
N/A 2031-11-01 |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
52,753 | $0 | 52,753 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 5:19 pm |
N/A 2031-02-25 |
Millendo Therapeutics Inc. | MLND | Minai-Azary Jennifer Lynn Chief Financial Officer |
110,000 | $0 | 110,000 (Direct) |
View |
Ownership |
2021-02-09 4:36 pm |
N/A 2023-08-21 |
Millendo Therapeutics Inc. | MLND | Minai-Azary Jennifer Lynn Chief Financial Officer |
0 | $0 | 105,340 (Direct) |
View |